Potential activity of adiponectin‐expressing regulatory T cells against triple‐negative breast cancer cells through the cell‐in‐cell phenomenon

A population of regulatory T cells (Treg), which reside within thymic nurse cell complexes, express adiponectin and abrogate breast cancer development in transgenic mice. In this study, we examined whether adiponectin‐expressing Treg could impair triple‐negative breast cancer, which is defined by a lack of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor‐2.

[1]  Chiemi Saigo,et al.  Adiponectin‐expressing Treg cells in experimental thymic tumor model , 2023, Thoracic cancer.

[2]  Chiemi Saigo,et al.  Experimental model of micronodular thymic neoplasm with lymphoid stroma , 2022, Thoracic cancer.

[3]  L. Delort,et al.  Targeting Adiponectin in Breast Cancer , 2022, Biomedicines.

[4]  P. Park,et al.  Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming , 2022, Journal of experimental & clinical cancer research : CR.

[5]  Kazuhiro Yoshida,et al.  Human colorectal cancer-associated carbohydrate antigen on annexin A2 protein , 2021, Journal of Molecular Medicine.

[6]  A. Xu,et al.  Adiponectin-expressing Treg facilitate T lymphocyte development in thymic nurse cell complexes , 2021, Communications biology.

[7]  Kazuhiro Yoshida,et al.  Prognostic significance of LDL receptor-related protein 1B in patients with gastric cancer , 2021, Journal of Molecular Histology.

[8]  X. Bian,et al.  Triple-negative breast cancer molecular subtyping and treatment progress , 2020, Breast Cancer Research.

[9]  G. Reynolds,et al.  Hepatocytes Delete Regulatory T Cells by Enclysis, a CD4+ T Cell Engulfment Process , 2019, Cell reports.

[10]  Qiang Sun,et al.  Subtype-Based Prognostic Analysis of Cell-in-Cell Structures in Early Breast Cancer , 2019, Front. Oncol..

[11]  T. Shibata,et al.  Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma , 2019, Journal of Cancer Research and Clinical Oncology.

[12]  M. Overholtzer,et al.  Cell-in-cell phenomena in cancer , 2018, Nature Reviews Cancer.

[13]  B. Győrffy,et al.  ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis , 2017, Autophagy.

[14]  Shi-bing Wang,et al.  T-cadherin is associated with prognosis in triple-negative breast cancer , 2017, Oncology letters.

[15]  Kazuhiro Yoshida,et al.  Adiponectin and Intelectin-1: Important Adipokine Players in Obesity-Related Colorectal Carcinogenesis , 2017, International journal of molecular sciences.

[16]  T. Fujiwara,et al.  Tumor-specific delivery of biologics by a novel T-cell line HOZOT , 2016, Scientific Reports.

[17]  F. Yamasaki,et al.  Cell-in-cell structures formed between human cancer cell lines and the cytotoxic regulatory T-cell line HOZOT. , 2010, Journal of molecular cell biology.

[18]  F. Yamasaki,et al.  Interleukin-8 and RANTES are signature cytokines made by HOZOT, a new type of regulatory T cells. , 2009, Molecular immunology.

[19]  F. Yamasaki,et al.  IL-2-independent generation of FOXP3(+)CD4(+)CD8(+)CD25(+) cytotoxic regulatory T cell lines from human umbilical cord blood. , 2007, Experimental hematology.

[20]  H. Lodish,et al.  T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Y. Ohtsuki,et al.  Recent progress in T-cadherin (CDH13, H-cadherin) research. , 2001, Histology and histopathology.

[22]  J. Minna,et al.  Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. , 2001, Cancer research.

[23]  Y. Ohtsuki,et al.  Expression of T‐Cadherin (CDH13, H‐Cadherin) in Human Brain and Its Characteristics as a Negative Growth Regulator of Epidermal Growth Factor in Neuroblastoma Cells , 2000, Journal of neurochemistry.

[24]  Y. Ohtsuki,et al.  H‐cadherin expression in breast cancer , 1999, Histopathology.

[25]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[26]  Sam W. Lee.  H–cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer , 1996, Nature Medicine.

[27]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. J. Steinhaus.  Ueber Carcinom-Einschlüsse , 1891, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.